Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 52

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 literature risk publications COVID-19 articles interventions evidence chinese epidemic rhinosinusitis - objectivity training mers-cov videos
2 search 95 research case journals PPE guidelines trials infectious diseases diagnosis online scientific babies ICTV RNA
3 methods meta-analysis countries coronavirus medical infection recommendations TCM predictions chronic internet retracted mental syndrome mandarin
4 review reviews bibliometric clinical health cost living clinical ZIKV diagnostic users sss women middle unnatural
5 studies quality % 2020 public control guideline speech models severity SUPPLEMENTARY article health professionals approval developments
6 health % arab case reports science transmission antibiotics medicine zika vitamin ELECTRONIC paper neonatal pathogenesis compendium
7 identified high number 2019 ’s effectiveness rgs outcome prediction encephalitis MATERIAL chapter care proposals heparanase
8 research CI output treatment cited setting L-OVE connected reproducibility consensus authorized digest newborn MGBA MIR
9 relevant mortality USA patients newspapers priority randomised trials clinical trials servers clinical supplementary microarray emergency vaccine EBCH
10 development bias = sars-cov-2 SARS protective rcts model diagnostic criteria online version corroborative ill otitis john
11 based resilience total studies times masks HCAI outcomes preprints croup internet references proteins MHL otitis media storage
12 provide systematic field case series medicine evaluations register paraphasias preprint servers american sharing policy emergency care east sons
13 important studies united reports informatics healthcare updated traditional timeliness asthma access metrics stress committee youtube
14 knowledge cochrane library retrieved systematic review frequently influenza preventing SUC infectious atypical material scientific community professionals middle east respiratory syndrome wiley
15 data patients global series occupational hand prophylactic herbal pandemic children references centrality post-traumatic zoonoses bibliography
16 identify systematic reviews collaboration viral infectious disease infections antibiotic FCSQ outbreaks clinical research closure withdrawal october members acids
17 key significant published pregnancy news AECB updates COS modelling definitions information shows newborns ethical cards
18 respiratory resistance background papers MG prophylaxis xiaoyaosan days ALRI ward closure elsevier courses therapies biochemistry
19 findings assessed h-index affected numbers respiratory living systematic review randomized controlled trials epidemics sepsis ward issue designs 2007 disks
20 outbreak test analysis drugs asian people incorporated naming data hepatic online health information writing poor countries ethical approval FTA
21 areas low publication trial public health effective randomised chinese medicine studies AB sites request post-traumatic stress disorder gut weeks
22 specific heterogeneity ranked in vitro environmental hygiene advice measurement % point % facts usual HIV competencies
23 selected data extraction international collaboration RT-PCR ML handwashing adapted blood passenger lesions diffusion reproduction baby EC listed
24 approach library study COVID PHI settings cochrane central register of controlled trials HED airline symptom NHP tourism in-service clinical studies scoring
25 databases heart top vitro stem personal CENTRAL western medicine covid-19 statement SR/MA apologize usual care ebola respect
26 general results country virus TW contact central antidepressants peer review nomenclature ASE incubation children agents cochrane review
27 conducted performed documents trials SCI facilities national VKC epidemiological markers ARI misfolded newborn babies middle east respiratory syndrome coronavirus natural
28 including pooled bibliometric analysis asymptomatic HK measures evidence-based SFI publication presepsin article ERAD ill newborns taxonomy bioterrorism
29 describe = arab countries ribavirin newspaper studies organisations registry accessibility graphical readers time frame update animal cumulative
30 framework - related mothers emerging surveillance questions protocols medical journals vitamin c version machinery review authors microbiota
31 issues assessment international neurological analyzed economic disseminated ESWT nephrology NGS ARTI http://www.elsevier.com/locate/withdrawalpolicy resuscitation microbiome in-text
32 objectives smoking world chloroquine technology costs extract data cpms enhance panel turnover misfolded proteins intimate AGA up‐to‐date
33 themes respiratory viruses institutions evidence infectious community-based openly mesalamine beginning bronchiolitis open record mental well-being respiratory subscribers
34 results confidence psychology SARS GHI healthcare personnel PICO chinese herbal medicine prediction models displays file journal operatives media alphabetical
35 criteria moderate scopus database review health-related facemask versus remdesivir general population mirnas DOAJ nature violence association scoring systems
36 included included diseases 2019-ncov critical care H1N1 department kangfuxinye climate communicate biotorrents life mental health MERS core competencies
37 developing disease france HCQ disaster medicine personnel COVID-19 UC predicted seroepidemiologic engines community psychological health axis deliberate
38 system diabetes years therapeutics coverage hand hygiene rapid HF publication process vitamin d transfer intrinsically resuscitate OM sentences
39 limitations cochrane production severe published n=2 patients revman code polyposis meteorological experiments health workers national library of medicine includes
40 information quality assessment zoonotic testing impact practices centralised score e.g. chronic rhinosinusitis inaccessible affects EDC BMJ 2
41 2014 primary studies toxocariasis systematic highest cost-effectiveness obstetrical controlled dissemination VDD 61 composition abused host issue
42 disease high risk kingdom n=10 intervals absenteeism privatisation efficacy process ROSES‐I mirna IV certainty animal studies 10
43 implications criteria leishmaniasis causing scientific articles mgs traditional media COS-COVID incorporation paediatric incentives retract health draft 4
44 abstracts AMSTAR global level plasma structure distancing infectious morbidity clinical efficacy absent exterior nosocomial fact maternity ratification section
45 resources hypertension brazil manifestations occupational health airborne NHS traditional chinese medicine flooding common residing geographics health worker 71 1
46 gaps prevalence NRT convalescent hong LTCF aerosol cortex 73 acute invasive disordered respiratory virus vaccinology 5
47 methodology critically BACKGROUND clinical trials lancet social distancing apply treatment reproducible cold symptoms 019 intrinsically disordered proteins vertical transmission gut microbiota surface
48 articles cardiovascular disease carbapenem included kong economic evaluations peer-reviewed publications rate actionable etiologic evidence-based idea documented outbreaks spectrometry
49 importance physical disease productivity reported pluripotent mask caesarean section randomized published chronic cough level RB japanese strategies recombinant
50 lists odds social media cohort medical literature analyses caesarean CBM diseases classic visually regulation workers notes elemental